Skip to content
★ Sign in to follow
IC

Isan Chen

Tyra Biosciences, Inc.Mirati Therapeutics, Inc.
Total declarations
15
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (1 ops.)
€3.2M

Latest filing published 17 Sept 2021 for Tyra Biosciences, Inc..

Filing timeline

BuySale
Isan Chen

Insider track record

Disclosed buys
0
Disclosed sells
1
Signal history

Isan Chen: trading record in brief

Filings by Isan Chen span 2 companies, the busiest being Mirati Therapeutics, Inc. and Tyra Biosciences, Inc. Between 9 March 2015 and 17 September 2021, the trades on record add up to 15 filings.

Every open-market trade on record is a sale: 1 sale worth €3.2M. Besides market trades, the filings include 13 option exercises.

The newest entry dates from 17 September 2021: a transaction, in Tyra Biosciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Isan Chen

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations15 total
  • ●
    DirectorExecutivesTyra Biosciences, Inc.
    0SEC
    61,444 sharesCommon StockSEC:0000899243-21-036424:0
  • ◇
    EVP, Chief Medical OfficerExecutivesMirati Therapeutics, Inc.
    833,017 USD13SEC
    33,334 shares@ US$24.9918.9% of flowCommon StockSEC:0001214659-20-004484:0
  • ▼
    EVP, Chief Medical OfficerExecutivesMirati Therapeutics, Inc.
    4M USD34SEC
    33,334 shares@ US$105.0079.4% of flowCommon StockSEC:0001214659-20-004484:1
  • ◇
    EVP, Chief Medical OfficerExecutivesMirati Therapeutics, Inc.
    75,020 USD11SEC
    3,002 shares@ US$24.991.6% of flowCommon StockSEC:0001214659-20-000769:0
  • ◇
    EVP, Chief Medical OfficerExecutivesMirati Therapeutics, Inc.
    6,098 USD11SEC
    244 shares@ US$24.990.1% of flowCommon StockSEC:0001214659-19-000538:0
  • ◇
    EVP, Chief Medical OfficerExecutivesMirati Therapeutics, Inc.
    13,444 USD11SEC
    625 shares@ US$21.510.3% of flowCommon StockSEC:0001214659-19-000538:1
  • ◇
    EVP, Chief Medical OfficerExecutivesMirati Therapeutics, Inc.
    5 USD11SEC
    1 shares@ US$5.400.0% of flowCommon StockSEC:0001214659-19-000538:2
  • ◇
    EVP, Chief Medical OfficerExecutivesMirati Therapeutics, Inc.
    4,788 USD11SEC
    275 shares@ US$17.410.1% of flowCommon StockSEC:0001214659-18-004880:0
  • ◇
    EVP, Chief Medical OfficerExecutivesMirati Therapeutics, Inc.
    34,244 USD11SEC
    1,592 shares@ US$21.510.7% of flowCommon StockSEC:0001214659-18-004880:1
  • ◇
    EVP, Chief Medical OfficerExecutivesMirati Therapeutics, Inc.
    11 USD11SEC
    2 shares@ US$5.400.0% of flowCommon StockSEC:0001214659-18-003060:0
  • ◇
    EVP, Chief Medical OfficerExecutivesMirati Therapeutics, Inc.
    159,858 USD11SEC
    10,124 shares@ US$15.793.0% of flowCommon StockSEC:0001214659-18-003060:1
  • ◇
    EVP, Chief Medical OfficerExecutivesMirati Therapeutics, Inc.
    7,173 USD11SEC
    412 shares@ US$17.410.1% of flowCommon StockSEC:0001214659-18-003060:2
  • ◇
    EVP, Chief Medical OfficerExecutivesMirati Therapeutics, Inc.
    53,775 USD11SEC
    2,500 shares@ US$21.511.0% of flowCommon StockSEC:0001214659-18-003060:3
  • ◇
    Sr.Vice President, Chief MediExecutivesMirati Therapeutics, Inc.
    0SEC
    2,542 sharesCommon StockSEC:0001190725-16-000300:0
  • ◇
    Chief Medical & Dev't OfficerExecutivesMirati Therapeutics, Inc.
    199,996 USD0SEC
    12,666 shares@ US$15.79Common StockSEC:0001209191-15-024978:0

15 of 15 declarations